The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome
Open accessAbstract
OBJECTIVE: Hyperuricemia is strongly associated with obesity and metabolic syndrome and can predict visceral obesity and insulin resistance. Previously, we showed that soluble uric acid directly stimulated the redox-dependent proinflammatory signaling in adipocytes. In this study we demonstrate the role of hyperuricemia in the production of key adipokines. RESEARCH DESIGN AND METHODS: We used mouse 3T3-L1 adipocytes, human primary adipocytes, and a mouse model of metabolic syndrome and hyperuricemia. RESULTS: Uric acid induced in vitro an increase in the production (mRNA and secreted protein) of monocyte chemotactic protein-1 (MCP-1), an adipokine playing an essential role in inducing the proinflammatory state in adipocytes in obesity. In addition, uric acid caused a decrease in the production of adiponectin, an adipocyte-specific insulin sensitizer and anti-inflammatory agent. Uric acid–induced increase in MCP-1 production was blocked by scavenging superoxide or by inhibiting NADPH oxidase and by stimulating peroxisome-proliferator–activated receptor-γ with rosiglitazone. Downregulation of the adiponectin production was prevented by rosiglitazone but not by antioxidants. In obese mice with metabolic syndrome, we observed hyperuricemia. Lowering uric acid in these mice by inhibiting xanthine oxidoreductase with allopurinol could improve the proinflammatory endocrine imbalance in the adipose tissue by reducing production of MCP-1 and increasing production of adiponectin. In addition, lowering uric acid in obese mice decreased macrophage infiltration in the adipose tissue and reduced insulin resistance. CONCLUSIONS: Hyperuricemia might be partially responsible for the proinflammatory endocrine imbalance in the adipose tissue, which is an underlying mechanism of the low-grade inflammation and insulin resistance in subjects with the metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Adiponectin and Adiponectin Receptors
Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Self-citationAdipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
Obesity-induced inflammatory changes in adipose tissue
Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Monocyte chemoattractant protein 1 in obesity and insulin resistance
Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Adipokines: molecular links between obesity and atheroslcerosis
Lau, D. C. W., Dhillon, B., Yan, H., Szmitko, P. E., & Verma, S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01058.2004 · Cited by 931
Kang, D.-H., Park, S.-K., Lee, I.-K., & Johnson, R. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050572 · Cited by 882
Self-citationSautin, Y. Y., Nakagawa, T., Zharikov, S., & Johnson, R. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00600.2006 · Cited by 787
Self-citationKanellis, J., Watanabe, S., Li, J. H., Kang, D. H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H. Y., Feng, L., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000072820.07472.3b · Cited by 786
Self-citationAdiponectin: action, regulation and association to insulin sensitivity
Lihn, A. S., Pedersen, S. B., & Richelsen, B. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00159.x · Cited by 660
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Metabolic Syndrome: A Clinical and Molecular Perspective
Moller, D. E., & Kaufman, K. D. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104751 · Cited by 631
Masuo, K., Kawaguchi, H., Mikami, H., Ogihara, T., & Tuck, M. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000091371.53502.d3 · Cited by 516
Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Johnson, R. J., Perez-Pozo, S. E., Sautin, Y. Y., Manitius, J., Sanchez-Lozada, L. G., Feig, D. I., Shafiu, M., Segal, M., Glassock, R. J., Shimada, M., et al. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0033 · Cited by 505
Self-citationYAMAMOTO, Y., HIROSE, H., SAITO, I., TOMITA, M., TANIYAMA, M., MATSUBARA, K., OKAZAKI, Y., ISHII, T., NISHIKAI, K., & SARUTA, T. (2002) · Clinical Science · doi:10.1042/cs1030137 · Cited by 490
Relationship Between Serum Uric Acid Concentration and Insulin Resistance and Metabolic Syndrome
Yoo, T. W., Sung, K. C., Shin, H. S., Kim, B. J., Kim, B. S., Kang, J. H., Lee, M. H., Park, J. R., Kim, H., Rhee, E. J., et al. (2005) · Circulation Journal · doi:10.1253/circj.69.928 · Cited by 412
Tsuchida, A., Yamauchi, T., Takekawa, S., Hada, Y., Ito, Y., Maki, T., & Kadowaki, T. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3358 · Cited by 409
Hayden, M. R., & Tyagi, S. C. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-10 · Cited by 397
Nakanishi, N., Okamoto, M., Yoshida, H., Matsuo, Y., Suzuki, K., & Tatara, K. (2003) · European Journal of Epidemiology · doi:10.1023/a:1024600905574 · Cited by 383
Matsuura, F., Yamashita, S., Nakamura, T., Nishida, M., Nozaki, S., Funahashi, T., & Matsuzawa, Y. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90346-8 · Cited by 362
Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link?
Johnson, R. J., Segal, M. S., Srinivas, T., Ejaz, A., Mu, W., Roncal, C., Sánchez-Lozada, L. G., Gersch, M., Rodriguez-Iturbe, B., Kang, D.-H., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010063 · Cited by 280
Self-citationTranscriptional and post-translational regulation of adiponectin
Liu, M., & Liu, F. (2010) · Biochemical Journal · doi:10.1042/bj20091045 · Cited by 235
Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease
Matsuzawa, Y. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.003 · Cited by 229
Uric acid, evolution and primitive cultures
Johnson, R. J., Titte, S., Cade, J. R., Rideout, B. A., & Oliver, W. J. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.09.002 · Cited by 225
Self-citationUric Acid, the Metabolic Syndrome, and Renal Disease
Cirillo, P., Sato, W., Reungjui, S., Heinig, M., Gersch, M., Sautin, Y., Nakagawa, T., & Johnson, R. J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080909 · Cited by 203
Self-citationXanthine Oxidoreductase Is a Regulator of Adipogenesis and PPARγ Activity
Cheung, K. J., Tzameli, I., Pissios, P., Rovira, I., Gavrilova, O., Ohtsubo, T., Chen, Z., Finkel, T., Flier, J. S., & Friedman, J. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.005 · Cited by 187
Ruan, H., Pownall, H. J., & Lodish, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303141200 · Cited by 185
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice
Kosugi, T., Nakayama, T., Heinig, M., Zhang, L., Yuzawa, Y., Sanchez-Lozada, L. G., Roncal, C., Johnson, R. J., & Nakagawa, T. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00092.2009 · Cited by 172
Self-citationThe kidney: an unwilling accomplice in syndrome X
Reaven, G. M. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90106-2 · Cited by 145
Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia
Zavaroni, I., Mazza, S., Fantuzzi, M., Dall’Aglio, E., Bonora, E., Delsignore, R., Passeri, M., & Reaven, G. M. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00700.x · Cited by 129
The role of the adipocyte hormone adiponectin in cardiovascular disease
Hug, C., & Lodish, H. F. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.001 · Cited by 126
Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases
Peelman, F., Waelput, W., Iserentant, H., Lavens, D., Eyckerman, S., Zabeau, L., & Tavernier, J. H. (2004) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.03.001 · Cited by 122
Relationship between Hyperuricemia and Body Fat Distribution
Hikita, M., Ohno, I., Mori, Y., Ichida, K., YOKOSE, T., & Hosoya, T. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0045 · Cited by 120
Tamba, S., Nishizawa, H., Funahashi, T., Okauchi, Y., Ogawa, T., Noguchi, M., Fujita, K., Ryo, M., Kihara, S., Iwahashi, H., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0603 · Cited by 104
Serum leptin is associated with serum uric acid concentrations in humans
Fruehwald‐Schultes, B., Peters, A., Kern, W., Beyer, J., & Pfützner, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90163-4 · Cited by 97
Plasma Adiponectin Levels and Metabolic Factors in Nondiabetic Adolescents
Huang, K., Lue, B., Yen, R., Shen, C. G., Ho, S., Tai, T. Y., & Yang, W. (2004) · Obesity Research · doi:10.1038/oby.2004.16 · Cited by 77
Erdely, A., Wagner, L. J., Müller, V., Szabo, A. J., & Baylis, C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000086476.48686.7d · Cited by 63
Self-citation
Cited by
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
Self-citationSugar, Uric Acid, and the Etiology of Diabetes and Obesity
Johnson, R. J., Nakagawa, T., Sanchez-Lozada, L. G., Shafiu, M., Sundaram, S., Le, M., Ishimoto, T., Sautin, Y. Y., & Lanaspa, M. A. (2013) · Diabetes · doi:10.2337/db12-1814 · Cited by 760
Self-citationUric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress
Lanaspa, M. A., Sanchez-Lozada, L. G., Choi, Y.-J., Cicerchi, C., Kanbay, M., Roncal-Jimenez, C. A., Ishimoto, T., Li, N., Marek, G., Duranay, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399899 · Cited by 710
Self-citationJohnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
Self-citationThe pathophysiology of hypertension in patients with obesity
DeMarco, V. G., Aroor, A. R., & Sowers, J. R. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.44 · Cited by 545
Metadata
- Authors
- Baldwin, W., McRae, S., Marek, G., Wymer, D., Pannu, V., Baylis, C., Johnson, R. J., & Sautin, Y. Y.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-03-22
- Volume
- 60
- Issue
- 4
- Pages
- 1258-1269
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2142436219
- Cited by
- 440
- References
- 49
- FWCI
- 17.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.